LEVIN JEREMY M 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:15 pm Sale | 2023-12-31 | 13G | Ovid Therapeutics Inc. OVID | LEVIN JEREMY M | 6,942,181 9.400% | -338,940 (-4.66%) | Filing |
| 2023-02-14 4:01 pm Purchase | 2022-12-31 | 13G | Ovid Therapeutics Inc. OVID | LEVIN JEREMY M | 7,281,121 10.000% | 726,351 (+11.08%) | Filing |
| 2022-02-14 4:31 pm Purchase | 2021-12-31 | 13G | Ovid Therapeutics Inc. OVID | LEVIN JEREMY M | 6,554,770 9.400% | 462,500 (+7.59%) | Filing |
| 2021-02-16 4:37 pm Purchase | 2020-12-31 | 13G | Ovid Therapeutics Inc. OVID | LEVIN JEREMY M | 6,092,270 9.600% | 369,337 (+6.45%) | Filing |
| 2020-02-14 09:26 am Sale | 2019-12-31 | 13G | Ovid Therapeutics Inc. OVID | LEVIN JEREMY M | 5,722,933 11.700% | -78,095 (-1.35%) | Filing |